At the news
? MIXEDIMPACT 6/10 8-K filed Feb 25, 2026 at 16:07 ET
Agilon Health reported a decline in financial performance for fiscal year 2025, with revenue down 2%, gross loss of $160M, and Adjusted EBITDA loss of $296M. However, the company issued 2026 guidance projecting a return to breakeven Adjusted EBITDA, driven by improved rates, cost discipline, and portfolio optimization. This combination of poor results with optimistic forward guidance creates a mixed outlook.
- 2025 revenue decreased 2% YoY to $5.93B
- Gross loss was $160M in 2025 vs. $5M profit in 2024
- Adjusted EBITDA loss was $296M in 2025 vs. $154M loss in 2024
- 2026 guidance projects Adjusted EBITDA breakeven at midpoint
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access